Anticoagulation in pregnancy and the puerperium

Medical Journal of Australia

Volumn 175, Issue 5, 2001, Pages 258-263

  Hague, W M ^a   North, R A ^a   Gallus, A S ^a   Walters, B N J ^a   Orlikowski, C ^a   Burrows, R F ^a   Cincotta, R B ^a   Dekker, G A ^a   Higgins, J R ^a   Lowe, S A ^a   Morris, J M ^a   Peek, M J ^a  

^a WOMEN S AND CHILDREN S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; DALTEPARIN; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PROTAMINE;

ACUTE DISEASE; ANAMNESIS; ANTICOAGULANT THERAPY; ANTICOAGULATION; ANTIPHOSPHOLIPID SYNDROME; DEEP VEIN THROMBOSIS; DELIVERY; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG ANTAGONISM; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG HALF LIFE; DRUG SAFETY; DRUG WITHDRAWAL; GENETIC ASSOCIATION; HEART VALVE PROSTHESIS; HIGH RISK PATIENT; HUMAN; HYPERHOMOCYSTEINEMIA; MEDICAL SPECIALIST; PATIENT GUIDANCE; PERINATAL PERIOD; PLACENTA INSUFFICIENCY; POPULATION RESEARCH; PRACTICE GUIDELINE; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; PRENATAL PERIOD; PROPHYLAXIS; PROTHROMBIN TIME; PUERPERIUM; RECURRENCE RISK; RECURRENT DISEASE; REGIONAL ANESTHESIA; REVIEW; RISK ASSESSMENT; RISK FACTOR; SPONTANEOUS ABORTION; THROMBOPHILIA; THROMBOSIS PREVENTION; TIME; TREATMENT PLANNING;

EID: 0035801622     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2001.tb143561.x     Document Type: Review

References (38)

1. Drug therapy: Low molecular weight heparins
2. Placental transport of heparin
3. Absence of transplacental passage of fragmin (Kabi) during the second and third trimesters of pregnancy
4. Bone mineral density during long-term prophylaxis with heparin in pregnancy
5. The effects of long-term heparin therapy during pregnancy on bone density - A prospective matched cohort study
6. A prospective study of heparin-induced osteoporosis in pregnancy using bone densitometry
7. Heparin-induced osteoporosis in pregnancy
8. Heparin, osteoporosis and pregnancy
9. Use of antithrombotic agents during pregnancy
10. Safety of low molecular weight heparin in pregnancy: A systematic review
11. Thrombosis in pregnancy: Maternal and fetal issues
12. Current concepts: Venous thromboembolism during pregnancy
13. Management of anticoagulation before and after elective surgery
14. Low molecular weight heparin versus warfarin in the prevention of recurrences after deep vein thrombosis
15. Venographic comparison of subcutaneous low-molecular weight heparin with oral anticoagulant therapy in the long-term treatment of deep venous thrombosis
16. Low molecular weight heparin versus warfarin for prevention of recurrent venous thromboembolism: A randomized trial
17. European practice guidelines: Thromboembolism prophylaxis and regional anesthesia
18. Deep vein thrombosis during pregnancy and the puerperium: A meta-analysis of the period of risk and the leg of presentation
19. The role of inherited thrombophilia in venous thromboembolism associated with pregnancy
20. Safety of withholding antepartum heparin in women with a previous episode of venous thromboembolism
21. Peripartum prophylaxis of thrombo-embolism
22. Venous thrombosis: A multicausal disease
23. Increased fetal loss in women with heritable thrombophilia
24. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium
25. Genetic susceptibility to venous thrombosis
26. Anticoagulation of pregnant women with mechanical heart valves - A systematic review of the literature
27. Is there a safe anticoagulation protocol for pregnant women with prosthetic valves?
28. Pregnancy through a prosthetic heart valve
29. Low molecular weight heparin for thromboprophylaxis during pregnancy in 2 patients with mechanical mitral valve replacement
30. Pregnancy outcomes and cardiac complications in women with mechanical, bioprosthetic and homograft valves
31. Enoxaparin treatment in women with mechanical heart valves during pregnancy
32. Antiplatelet agents for preventing and treating pre-eclampsia
33. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)
34. Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin
35. Low-molecular-weight heparin combined with aspirin in pregnant women with thrombophilia and a history of preeclampsia or fetal growth restriction: A preliminary study